TwoStep Therapeutics is developing novel tumor-targeting therapeutics for solid tumors.
TwoStep Therapeutics has raised $62.5M in total funding. The most recent round was Series A. The last funding was announced in September 2026.
TwoStep Therapeutics's investors include Insight Partners, NFX, Medical Excellence Capital, 2048 Ventures, Pfizer Venture Investments.
TwoStep Therapeutics is headquartered in Palo Alto, United States.
TwoStep Therapeutics is developing novel tumor-targeting therapeutics for solid tumors.
TwoStep Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"TwoStep Therapeutics — Funding & Investors." VCBacked, September 9, 2026, https://www.vcbacked.co/company/twostep-therapeutics. Accessed October 11, 2026.
VCBacked. (2026). TwoStep Therapeutics — Funding & Investors. Retrieved October 11, 2026, from https://www.vcbacked.co/company/twostep-therapeutics
{{cite web |title=TwoStep Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/twostep-therapeutics |website=VCBacked |access-date=October 11, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated